Wockhardt News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Wockhardt from all sources in a single place.

Wockhardt Ltd.

25 Aug 2026

2179.40

-1.86%

Corp. Note

Wockhardt Ltd - 532300 - Disclosure under Regulation 30A of LODR

BSE India

Pursuant to Regulation 30 (read with Part A of Schedule III) of SEBI (LODR) Regulations 2015, we wish to inform you that the Company is in receipt of an Adjudication Order passed by Commissioner of Customs, Nhava Sheva-II, JNCH.

pdf

Wockhardt Ltd.

25 Aug 2026

2179.40

-1.86%

Company Update

Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 30 read with Schedule III Part A Para A of the SEBI (LODR) Regulations, 2015, we enclose herewith a copy of newspaper advertisement published today i.e. 25th August, 2026 regarding the opening of special window for re-lodgment of transfer requests of shares held in physical form

pdf

Wockhardt Ltd.

10 Aug 2026

2179.40

-1.86%

With a pipeline of antibiotics, Wockhart looks to build a conversation on rational use and resistance

Business Line

Wockhardt Antibiotic Academy to be an open scientific learning platform to facilitate continuous medical education among healthcare professionals, says Founder Chairman Habil Khorakiwala

Wockhardt Ltd. is trading above all available SMAs

Wockhardt Ltd.

10 Aug 2026

2179.40

-1.86%

AGM

Wockhardt Ltd - 532300 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

Please find enclosed herewith Scrutinizer''s Report on the combined voting results of remote e-voting and e-voting during the 27th AGM of the Company

pdf

Wockhardt Ltd.

10 Aug 2026

2179.40

-1.86%

AGM

Wockhardt Ltd - 532300 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

Pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (LODR) Regulations, 2015, the Proceedings of the 27th AGM of the Company

pdf

Wockhardt Ltd.

10 Aug 2026

2179.40

-1.86%

Wockhardt Q1 results: Revenue rises 26% to 929 cr, profit at 107 cr

Business Standard

Pharmaceuticals firm Wockhardt Ltd on Monday reported a consolidated profit after tax of Rs 107 crore for the first quarter ended June 30, mainly due to strong revenue growth. The company had posted a consolidated net loss of Rs 108 crore in the corresponding period of the last fiscal, Wockhardt Ltd said in a regulatory filing. Its consolidated revenue from operations in the first quarter stood at Rs 929 crore against Rs 738 crore a year ago, it added. Total expenses in the quarter under review were higher at Rs 844 crore compared to Rs 770 crore in the year-ago period, it said.

Wockhardt has gained 17.97% in the last 1 Month

Wockhardt Ltd.

10 Aug 2026

2179.40

-1.86%

Company Update

Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

BSE India

Pursuant to Regulation 32(6) of SEBI (LODR) Regulations 2015, read with Regulation 173A of SEBI (ICDR) Regulations, 2018, please find enclosed Monitoring Agency Report towards utilisation of proceeds of Qualified Institutions Placement (QIP) for the quarter ended 30th June, 2026 issued by CRISIL Ratings Limited, duly reviewed and taken on record by the Board of Directors and Audit Committee of the Company.

pdf

Wockhardt Ltd.

10 Aug 2026

2179.40

-1.86%

Company Update

Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Please find enclosed Press Release - "Wockhardt Antibiotic Academy, an initiative for Patient-Centric Scientific Dialogue to Tackle Multidrug Resistance".

pdf

Wockhardt Ltd.

10 Aug 2026

2179.40

-1.86%

Company Update

Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Pursuant to Regulation 30 of Listing Regulations, please find enclosed Press Release on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June, 2026

pdf